Published in Parasitol Res on May 08, 2010
In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection. Parasit Vectors (2014) 0.89
Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo (1963) 3.16
Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz (2009) 2.58
Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol (1968) 2.45
Ancestral genomes, sex, and the population structure of Trypanosoma cruzi. PLoS Pathog (2006) 1.75
Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol (1999) 1.49
Biological aspects of the Dm 28c clone of Trypanosoma cruzi after metacyclogenesis in chemically defined media. Mem Inst Oswaldo Cruz (1989) 1.47
Brazilian isolates of Trypanosoma cruzi from humans and triatomines classified into two lineages using mini-exon and ribosomal RNA sequences. Am J Trop Med Hyg (1998) 1.27
Activation of transcription factors AP-1 and NF-kappa B in murine Chagasic myocarditis. Infect Immun (2003) 1.07
Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc Pathol (2000) 1.05
Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. Am J Pathol (2004) 0.98
Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis. Virchows Arch (2001) 0.98
Protocol to refine intestinal motility test in mice. Lab Anim (2004) 0.91
A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase. Am J Trop Med Hyg (2008) 0.88
Trypanosoma cruzi: both chemically induced and triatomine-derived metacyclic trypomastigotes cause the same immunological disturbances in the infected mammalian host. Exp Parasitol (1995) 0.87
The role of selenium in intestinal motility and morphology in a murine model of Typanosoma cruzi infection. Parasitol Res (2010) 0.85
Applicability of the use of charcoal for the evaluation of intestinal motility in a murine model of Trypanosoma cruzi infection. Parasitol Res (2007) 0.84
Glial fibrillary acidic protein and S-100 colocalization in the enteroglial cells in dilated and nondilated portions of colon from chagasic patients. Hum Pathol (2008) 0.81
Infection with different Trypanosoma cruzi populations in rats: myocarditis, cardiac sympathetic denervation, and involvement of digestive organs. Am J Trop Med Hyg (2000) 0.79
Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-n-propylquinoline. Phytother Res (2001) 0.78
Trypanosoma cruzi: dehydroepiandrosterone (DHEA) and immune response during the chronic phase of the experimental Chagas' disease. Vet Parasitol (2009) 0.77
[Chagas disease]. Rev Med Interne (2009) 0.77
Interstitial cells of Cajal in patients with chagasic megacolon originating from a region of old endemicity. Pathophysiology (2006) 0.76
Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease. Antimicrob Agents Chemother (2009) 1.02
A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease. Int J Antimicrob Agents (2010) 0.99
Magnetic resonance imaging in experimental Chagas disease: a brief review of the utility of the method for monitoring right ventricular chamber dilatation. Parasitol Res (2005) 0.96
Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion. Am J Pathol (2005) 0.92
The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice. Mem Inst Oswaldo Cruz (2010) 0.91
SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion. Antimicrob Agents Chemother (2007) 0.88
Trypanosoma cruzi: host selenium deficiency leads to higher mortality but similar parasitemia in mice. Exp Parasitol (2002) 0.87
Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease. PLoS Negl Trop Dis (2012) 0.86
Progressive Chagas' cardiomyopathy is associated with low selenium levels. Am J Trop Med Hyg (2002) 0.85
The role of selenium in intestinal motility and morphology in a murine model of Typanosoma cruzi infection. Parasitol Res (2010) 0.85
Selenium supplementation at low doses contributes to the decrease in heart damage in experimental Trypanosoma cruzi infection. Parasitol Res (2003) 0.84
Applicability of the use of charcoal for the evaluation of intestinal motility in a murine model of Trypanosoma cruzi infection. Parasitol Res (2007) 0.84
Would selenium supplementation aid in therapy for Chagas disease? Trends Parasitol (2011) 0.77
[The design and promotion of health in the Fiocruz research laboratories]. Hist Cienc Saude Manguinhos (2009) 0.75
Introducing DNA concepts to Swiss high school students based on a Brazilian educational game. Biochem Mol Biol Educ (2007) 0.75